The nucleotide-binding domain, leucine-rich–containing family, pyrin domain–containing-3 (NLRP3) inflammasome, which is responsible for the activation of IL-1β and IL-18, has been increasingly recognized as an essential contributor to the development and progression of MASLD [55]. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatotic liver disease.